Microglia-derived ASC specks cross-seed amyloid-β in Alzheimer's disease

Carmen Venegas1, Sathish Kumar2, Bernardo S Franklin3

  • 1Department of Neurodegenerative Diseases and Gerontopsychiatry, University of Bonn, Sigmund-Freud-Strasse 25, 53127 Bonn, Germany.

Nature
|January 3, 2018
PubMed

Insights

Inflammasome-activated ASC specks released by microglia act as a cross-seed, driving amyloid-beta pathology spread in Alzheimer's disease models. Blocking ASC specks reduces this pathology, highlighting inflammasome activation's role.

Area of Science:

  • Neuroscience
  • Immunology
  • Pathology

Background:

  • Neurodegenerative disorders feature pathology spread within and between brain areas.
  • Alzheimer's disease involves amyloid-beta deposition, innate immune activation, and inflammasome-dependent ASC speck formation in microglia.

Purpose of the Study:

  • To investigate the role of inflammasome-derived ASC specks in seeding and spreading amyloid-beta pathology.
  • To determine if ASC specks act as a cross-seed for amyloid-beta pathology in Alzheimer's disease.

Main Methods:

  • Intrahippocampal injection of ASC specks into APPSwePSEN1dE9 mice.
  • Utilizing ASC-deficient APPSwePSEN1dE9 mice to assess pathology induction.
  • Employing an anti-ASC antibody to block ASC speck effects.

Main Results:

  • Intrahippocampal injection of ASC specks induced spreading of amyloid-beta pathology in APPSwePSEN1dE9 mice.
  • Brain homogenates from APPSwePSEN1dE9 mice failed to induce pathology in ASC-deficient mice.
  • Co-application of anti-ASC antibody inhibited the increase in amyloid-beta pathology.

Conclusions:

  • Inflammasome activation and ASC speck formation are linked to the seeding and spreading of amyloid-beta pathology.
  • ASC specks function as an inflammation-driven cross-seed for amyloid-beta pathology.
  • These findings support inflammasome activation as a key factor in Alzheimer's disease progression.